Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines

Usefulness of omalizumab in ten patients with severe occupational asthma

(2013) F. Lavaud et al.   ALLERGY

Characterization of different courses of atopic dermatitis in adolescent and adult patients

(2013) D. Garmhausen et al.   ALLERGY

Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma

(2013) J. S. Ried et al.   ALLERGY

Anti-IgE – emerging opportunities for Omalizumab

(2013) K Suresh Babu et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Allergic Asthmatics Show Divergent Lipid Mediator Profiles from Healthy Controls Both at Baseline and following Birch Pollen Provocation

(2012) Susanna L. Lundström et al.   PLoS One

Atopic dermatitis - from new pathophysiologic insights to individualized therapy

(2011) N. Novak et al.   ALLERGY

Role of immunmodulators in allergen-specific immunotherapy

(2011) M. V. Kopp   ALLERGY

Can anti-IgE therapy prevent airway remodeling in allergic asthma?

(2011) K. F. Rabe et al.   ALLERGY

Allergic bronchopulmonary aspergillosis and omalizumab

(2011) I. Tillie-Leblond et al.   ALLERGY

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma

(2011) J. Bousquet et al.   ALLERGY

TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls

(2011) A.-C. Almstrand et al.   EUROPEAN RESPIRATORY JOURNAL

Omalizumab - an effective and safe treatment of therapy-resistant chronic spontaneous urticaria

(2010) A. Groffik et al.   ALLERGY

Metabolic Abnormalities in Children with Asthma

(2010) Lesley Cottrell et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Lipid signalling in disease

(2008) Matthias P. Wymann et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY